Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Irbesartan (Primary) ; Ciprofibrate
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacodynamics
- Sponsors Sanofi
- 17 Sep 2007 Status changed from in progress to completed.
- 12 Sep 2006 New trial record.